Atlas Trials

Pharmacokinetics, Acceptability and Safety of Famciclovir in Infants (1 Month to Less Than 12 Months) With Herpes Simplex Infection

Clinical trial NCT00448227 · COMPLETED

Trial details

NCT number
NCT00448227
Sponsor
Novartis
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Herpes Simplex
Start date
2007-10-01
Primary completion
2008-11-01
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.